Previous 10 | Next 10 |
The S&P 500 ( SP500 ) slid nearly 3% for February, final figures showed on Tuesday, eating into the solid gains it had made in the first month of the new year. Sentiment was weighed down by hotter-than-expected inflation data and concerns over the Federal Reserve's rate hikes. Losses ...
Catalent, Inc. (NYSE: CTLT), the leader in enabling the development and supply of better treatments for patients worldwide, today published its fourth Corporate Responsibility Report for its fiscal year 2022, which ended June 30, 2022. The report highlights Catalent's progress against its previou...
Healthcare stocks were quite a mixed bag over the past few trading sessions, but one standout rising above the pack was contract drug manufacturer Catalent (NYSE: CTLT) . The company's shares got a nice lift after it reported quarterly results. The stock's price rose by nearly 26% over th...
Catalent, Inc. (CTLT) Q2 2023 Results Conference Call February 07, 2023 08:15 AM ET Company Participants Paul Surdez - Vice President, Investor Relations Alessandro Maselli - President & Chief Executive Officer Tom Castellano - Senior Vice President & Chief Fin...
Contract manufacturer Catalent, Inc. ( NYSE: CTLT ) stretched recent gains to add ~5% pre-market Tuesday after announcing an agreement with Moderna ( NASDAQ: MRNA ) to extend its pandemic-era collaboration. The company made the announcement with its Q2 FY23 results days af...
Catalent press release ( NYSE: CTLT ): Q2 Non-GAAP EPS of $0.67 misses by $0.02 . Revenue of $1.15B (-5.7% Y/Y) beats by $20M . Q2'23 Adjusted EBITDA of $283M decreased 9% as reported, or 6% in constant currency, compared to Q2'22. Catalent reiterates full-year gui...
Q2'23 net revenue of $1.15 billion decreased 6% as reported, or 2% in constant currency (1) , compared to Q2'22. Organic, constant-currency net revenue decreased by 4%, compared to Q2'22. Q2'23 net earnings of $81 million. Q2'23 Adjusted EBITDA (1) of $283 million ...
Catalent closed Monday up ~20% on Monday following a report over the weekend that Danaher ( NYSE: DHR ) was interested in acquiring the contract manufacturer . BofA Securities analyst Michael Ryskin said that the premium Danaher ( DHR ) would have to pay for such a deal is...
Wall Street opened the new week on a downbeat note, with major stock market benchmarks mostly moving lower. The Nasdaq Composite (NASDAQINDEX: ^IXIC) was down more than 1% at its low point Monday morning, although it rebounded to cut its losses by noon ET. Investors have looked for wa...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: aerogondo2 / Shutterstock.com Newmont (NYSE: NEM ) stock is in the news Monday as the company reveals plans to purchase Newcrest Mining . Newcrest Mining is the largest gold miner in Australia. Newmont...
News, Short Squeeze, Breakout and More Instantly...
Expansion adds more temperature-controlled storage and dedicated space for FastChain ® demand-led supply service Catalent, Inc. (NYSE: CTLT), the leader in enabling the development and supply of better treatments for patients worldwide, today announced it has completed expansio...
2024-06-30 17:48:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-28 07:15:04 ET Barclays analyst issues EQUAL-WEIGHT recommendation for CTLT on June 28, 2024 05:28AM ET. The previous analyst recommendation was Equal-Weight. CTLT was trading at $56.41 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...